Kura Oncology
San Diego, CA
Kura Oncology, Inc. operates as a clinical stage biopharmaceutical company. The Company focuses on discovery and development of personalized therapeutics for the treatment of tumors and blood cancers. Kura Oncology offers development programs for cancers with high unmet need, including lung, colorectal, thyroid, blood, and pancreatic cancers.
kuraoncology.comCompany Details
Founded
- 2014
Employees
- 192 employees
Raised
- $1,241,425,536
Headquarters Location
- San Diego, CA
Public
- Yes
Acquired
- No
CEO
Troy Wilson
Founders
- Troy WilsonAntonio GualbertoPingda RenYi Liu
Company Collections
These are collections Kura Oncology is a part of. Click on the collection name to view similar companies.
Kura Oncology's Industries
Kura Oncology's Tech Stack
Current Job Listings
Kura Oncology Headquarters Location
Total Amount Raised: $1,241,425,536
Kura Oncology Funding Rounds
Post Ipo Equity
$150,000,000
Post Ipo Equity Investors
Suvretta Capital ManagementEcoR1 CapitalDeerfield ManagementPost Ipo Equity
$100,000,000
Post Ipo Equity
$25,000,000
Post Ipo Equity Investors
Bristol-Myers Squibb CompanyPost Ipo Debt
$125,000,000
Post Ipo Debt Investors
Hercules CapitalPost Ipo Equity
$345,080,500
Post Ipo Equity
$143,900,000
Post Ipo Equity
$115,345,000
Post Ipo Equity
$77,050,000
Post Ipo Equity
$50,050,000
Post Ipo Equity
$50,000,000
Private Equity
$60,000,000
Private Equity Investors
EcoR1 CapitalArch Venture PartnersNextech InvestOsage University Partners IIFidelityTavistock GroupPartner Fund ManagementIPO
Unknown
Kura Oncology Reviews
0 out of 5 stars
Based on 0 reviews
Review data
Share your thoughts
Worked here? Share your experience. Help others decide if this company is right for them. Write a review on Kura Oncology.